2015 JSGE非酒精性脂肪性肝病/非酒精性脂肪性肝炎循证临床实践指南解读

被引:15
作者
董志霞
陆伦根
机构
[1] 上海交通大学附属第一人民医院消化科
关键词
非酒精性脂肪性肝病; 发病率; 肝功能; JSGE; NAFLD; 临床实践指南; 循证;
D O I
暂无
中图分类号
R575.5 [肝代谢障碍];
学科分类号
1002 ; 100201 ;
摘要
<正>在西方和许多亚洲国家,饮食和生活方式的改变导致肥胖和代谢综合征发生率显著增加,也导致了非酒精性脂肪性肝病(NAFLD)发病率显著增加。NAFLD包括非酒精性脂肪肝(NAFL)和非酒精性脂肪性肝炎(NASH)两种临床形式。NAFLD是目前最常见的慢性肝病,已成为重要的公共健康问题。因此需要NAFLD/NASH的循证临床实践指南,然而目前尚无足够的证据可以用于制定指南。此外,关于以酒精摄入的阈值来定义"非酒精性肝
引用
收藏
页码:19 / 22
页数:4
相关论文
共 13 条
[1]  
Evidence‐based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis[J] . Sumio Watanabe,Etsuko Hashimoto,Kenichi Ikejima,Hirofumi Uto,Masafumi Ono,Yoshio Sumida,Masataka Seike,Yoshiyuki Takei,Tetsuo Takehara,Katsutoshi Tokushige,Atsushi Nakajima,Masashi Yoneda,Toshiji Saibara,Goshi Shiota,Isao Sakaida,Makoto Nakamuta,Toshihiko Mizuta,Hirohito Tsubouchi,Kentaro Sugano,Tooru Shimosegawa.Hepatol Res . 2015 (4)
[2]  
The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology[J] . Naga Chalasani,Zobair Younossi,Joel E. Lavine,Anna Mae Diehl,Elizabeth M. Brunt,Kenneth Cusi,Michael Charlton,Arun J. Sanyal.Gastroenterology . 2012 (7)
[3]  
Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study[J] . Yuichiro Eguchi,Hideyuki Hyogo,Masafumi Ono,Toshihiko Mizuta,Naofumi Ono,Kazuma Fujimoto,Kazuaki Chayama,Toshiji Saibara.Journal of Gastroenterology . 2012 (5)
[4]  
Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis[J] . Herbert Tilg,Alexander R. Moschen.Hepatology . 2010 (5)
[5]  
Epidemiology of non-alcoholic fatty liver disease in China[J] . Jian-Gao Fan,Geoffrey C. Farrell.Journal of Hepatology . 2008 (1)
[6]  
Review article: epidemiology, pathogenesis and potential treatments of paediatric non‐alcoholic fatty liver disease[J] . N. J.BARSHOP,C. B.SIRLIN,J. B.SCHWIMMER,J. E.LAVINE.Alimentary Pharmacology & Therapeutics . 2008 (1)
[7]  
Association between serum TSH, free T4 and serum liver enzyme activities in a large cohort of unselected outpatients[J] . GiovanniTargher,MartinaMontagnana,GianlucaSalvagno,PaoloMoghetti,GiacomoZoppini,MicheleMuggeo,GiuseppeLippi.Clinical Endocrinology . 2007 (3)
[8]   Growth hormone reverses nonalcoholic steatohepatitis in a patient with adult growth hormone deficiency [J].
Takahashi, Yutaka ;
Iida, Keiji ;
Takahashi, Kentaro ;
Yoshioka, Shiro ;
Fukuoka, Hidenori ;
Takeno, Ryoko ;
Imanaka, Mari ;
Nishizawa, Hitoshi ;
Takahashi, Michiko ;
Seo, Yasushi ;
Hayashi, Yoshitake ;
Kondo, Takuma ;
Okimura, Yasuhiko ;
Kaji, Hidesuke ;
Kitazawa, Riko ;
Kitazawa, Sohei ;
Chihara, Kazuo .
GASTROENTEROLOGY, 2007, 132 (03) :938-943
[9]   In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease [J].
Wieckowska, Anna ;
Zein, Nizar N. ;
Yerian, Lisa M. ;
Lopez, A. Rocio ;
McCullough, Arthur J. ;
Feldstein, Ariel E. .
HEPATOLOGY, 2006, 44 (01) :27-33
[10]   Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction [J].
Adams, LA ;
Feldstein, A ;
Lindor, KD ;
Angulo, P .
HEPATOLOGY, 2004, 39 (04) :909-914